Muendlein A[au] - Search Results

Year	Number of Results
2004	2
2005	1
2007	2
2008	3
2009	4
2010	4
2011	5
2012	3
2013	3
2014	7
2015	11
2016	8
2017	4
2018	4
2019	12
2020	6
2021	5
2022	10
2023	2

1

Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography.

Muendlein A, Brandtner EM, Leiherer A, Geiger K, Heinzle C, Gaenger S, Fraunberger P, Mader A, Saely CH, Drexel H. Muendlein A, et al. Data Brief. 2022 Apr 9;42:108142. doi: 10.1016/j.dib.2022.108142. eCollection 2022 Jun. Data Brief. 2022. PMID: 35496482 Free PMC article.

2

Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography.

Muendlein A, Leiherer A, Saely C, Ebner J, Geiger K, Brandtner EM, Vonbank A, Fraunberger P, Drexel H. Muendlein A, et al. Data Brief. 2019 Jun 7;25:104109. doi: 10.1016/j.dib.2019.104109. eCollection 2019 Aug. Data Brief. 2019. PMID: 31334311 Free PMC article.

3

Volatilomic Signatures of AGS and SNU-1 Gastric Cancer Cell Lines.

Ślefarska-Wolak D, Heinzle C, Leiherer A, Ager C, Muendlein A, Mezmale L, Leja M, Corvalan AH, Drexel H, Królicka A, Shani G, Mayhew CA, Haick H, Mochalski P. Ślefarska-Wolak D, et al. Among authors: muendlein a. Molecules. 2022 Jun 22;27(13):4012. doi: 10.3390/molecules27134012. Molecules. 2022. PMID: 35807254 Free PMC article.

4

Serotonin is elevated in risk-genotype carriers of TCF7L2 - rs7903146.

Leiherer A, Muendlein A, Saely CH, Fraunberger P, Drexel H. Leiherer A, et al. Among authors: muendlein a. Sci Rep. 2019 Sep 6;9(1):12863. doi: 10.1038/s41598-019-49347-y. Sci Rep. 2019. PMID: 31492908 Free PMC article.

5

Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients.

Muendlein A, Brandtner EM, Leiherer A, Geiger K, Heinzle C, Gaenger S, Fraunberger P, Mader A, Saely CH, Drexel H. Muendlein A, et al. Atherosclerosis. 2022 Mar;345:33-38. doi: 10.1016/j.atherosclerosis.2022.02.015. Epub 2022 Feb 13. Atherosclerosis. 2022. PMID: 35202959

6

Evaluation of the association of serum glypican-4 with prevalent and future kidney function.

Muendlein A, Brandtner EM, Leiherer A, Geiger K, Heinzle C, Gaenger S, Fraunberger P, Haider D, Saely CH, Drexel H. Muendlein A, et al. Sci Rep. 2022 Jun 17;12(1):10168. doi: 10.1038/s41598-022-14306-7. Sci Rep. 2022. PMID: 35715556 Free PMC article.

7

Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.

Muendlein A, Severgnini L, Decker T, Heinzle C, Leiherer A, Geiger K, Drexel H, Winder T, Reimann P, Mayer F, Nonnenbroich C, Dechow T. Muendlein A, et al. Front Oncol. 2022 Oct 24;12:1045995. doi: 10.3389/fonc.2022.1045995. eCollection 2022. Front Oncol. 2022. PMID: 36353562 Free PMC article.

8

The value of uromodulin as a new serum marker to predict decline in renal function.

Leiherer A, Muendlein A, Saely CH, Brandtner EM, Geiger K, Fraunberger P, Drexel H. Leiherer A, et al. Among authors: muendlein a. J Hypertens. 2018 Jan;36(1):110-118. doi: 10.1097/HJH.0000000000001527. J Hypertens. 2018. PMID: 28858977

9

High betatrophin in coronary patients protects from cardiovascular events.

Leiherer A, Ebner J, Muendlein A, Brandtner EM, Zach C, Geiger K, Fraunberger P, Drexel H. Leiherer A, et al. Among authors: muendlein a. Atherosclerosis. 2020 Jan;293:62-68. doi: 10.1016/j.atherosclerosis.2019.11.011. Epub 2019 Nov 15. Atherosclerosis. 2020. PMID: 31862484

10

Real-time PCR based HLA-B*27 screening directly in whole blood.

Geiger K, Zach C, Leiherer A, Fraunberger P, Drexel H, Muendlein A. Geiger K, et al. Among authors: muendlein a. HLA. 2020 Mar;95(3):189-195. doi: 10.1111/tan.13767. Epub 2019 Dec 1. HLA. 2020. PMID: 31749313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results